Published • loading... • Updated
Succession at Basic Pharma: SHS Capital Acquires Majority Stake
Summary by bionity.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Healthcare investor SHS Capital has acquired a stake in Basic Pharma, a Dutch specialty pharmaceutical platform and full-service CDMO based in Geleen. The investment represents a succession plan for the founder and aims to establish Basic Pharma as a leading European specialty pharmaceutical platform.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
